Dr Sarah Cant, Policy Manager at Breakthrough Breast Cancer, says; "The decision to screen embryos to see whether they have a faulty breast cancer gene is a complex and very personal issue. Women with a family history of breast cancer tell us that what might be right for one person may not be right for another. It's important for anyone affected to have appropriate information and support so they can make the right choice for them.
More...
Linear Mode
